Cholera is a acute diarrhoeal disease caused by Vibrio cholerae.
Majority of infection are mild or asymptomatic.
IV B.PHARM, 8-SEMESTER ,SOCIAL AND PREVENTIVE PHARMACY.
CHOLERA DISESASE
DEFINITION, SYMPTOMS, CAUSES, TREATMENT, PREVENTION.
Shigellosis = inflammation of intestines (especially the colon) with accompanying severe abdominal cramps, tenesmus and frequent, low-volume stools containing blood, mucus and fecal leukocytes.
Shigellosis = inflammation of intestines (especially the colon) with accompanying severe abdominal cramps, tenesmus and frequent, low-volume stools containing blood, mucus and fecal leukocytes.
Typhoid fever is an infection caused by the bacterium Salmonella typhi.
Paratyphoid is an infection which is similar but has milder symptoms, which is caused by the bacterium Salmonella paratyphi.
Typhoid fever is an infection caused by the bacterium Salmonella typhi.
Paratyphoid is an infection which is similar but has milder symptoms, which is caused by the bacterium Salmonella paratyphi.
Cholera is an acute diarrheal illness caused by infection of the intestine with Vibrio cholerae bacteria. People can get sick when they swallow food or water contaminated with cholera bacteria. The infection is often mild or without symptoms, but can sometimes be severe and life-threatening.
A bunch of topic were selected for our subject Communicable Diseases, surprisingly I picked up "Cholera El tor"...
I have done enough research regarding this topic from Brunner and Suddarths MedSurg books and other resources. I collated the ideas and came up to this presentation...
Hope it will be able to help my colleagues, students and those people who needs to know the what, why's, and how of Cholera!
xoxo ^___^
Stability testing protocol for herbal products in a detailed review.It’s the ability of formulation to retain its physical, chemical, microbiological and toxicological parameter same as that time of manufacture .
Drug product remains within specifications established to ensure its identity, strength, quality and purity.
Stability – Chemical and Physical integrity of herbal medicinal products.
Over a given time period and under the influence of environmental factors including temperature, humidity and light.
To provide evidence on how the quality of active substance varies with time and environmental factors
To establish re- test period for active substance
To establish shelf life of finished products.
To recommend storage conditions.
To evaluate the efficacy of drug.
To develop suitable packing information for drug product
To submit stability information for regulatory agencies.
1.Physical stability study:-
The original physical properties namely appearance, uniformity, palatability, dissolution, and suspend ability are maintained.
Chemical stability study:-
Each and every active ingredient retains its chemical integrity as well as potency specified on label, within the specified limits.
It involves drug assay and determination of drug degradation.
FAIRNESS CREAM FORMULATIONS
PHARMACOGNOSY DATA FOR HERBAL COSMETICS, IT CONSISTS OF THE DATA ABOUT THE SKIN AND THE FORMULATION OF THE FAIRNESS CREAMS AND THEIR EVALUATION AND EFFECTS
DRUGS USED IN THE TREATMENT OF BRONCHIAL ASTHMA AND COPD
Characterized by hyper responsiveness of bronchial smooth muscle to a variety of stimuli”
Resulting in:
Narrowing of air ways
Increased secretion
Mucosal edema
Mucus plugging
The details about the elimination of the drug from the body by various methods. drug metabolism, drug transformation, drug elimination process. factors affecting.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
2. CHOLERA
Cholera is an acute diarrhoeal disease caused by Vibrio Cholerae O1 and V.Cholerae O139.
The majority of infections are mild or asympatomatic.
It mainly affect the lumen of the stomach.
It is characterized by intense vomiting and profuse watery diarrhoea and that rapidly leads to
dehydration and often death.
It is often mild or without symptoms.
It can affect all age groups and majorly children are affected
and may also leads to death.
INCUBATION PERIOD
Few hours up to 5 days , but commonly 1-2 days.
3. VIBRIO CHOLERAE
It is comma – shaped.
Gram negative , aerobic or facultative anaerobic bacillus.
Varies in sixe from 1-3Âμm in length by 0.5-0.8Âμm in diameter.
Grows in salt and fresh water.
Only O1 and O139 are toxigenic and cause cholera disease.
Its antigenic structure consists of
a. Flagellar H antigen
b. Somatic O antigen
Bacteria are easily destroyed by coaltar disinfectants such
as cresol and bleaching powder.
The vibrios multiply in the lumen of the small intestine
and produce an exotoxin.
5. MODE OF TRANSMISSION
A. FAECALLY CONTAMINATED WATER
Uncontrolled water sources such as wells, lakes, ponds, streams, and rivers.
B. CONTAMINATED FOOD AND DRINKS
Ingestion of contaminated food and drinks have been causes the cholera disease.
C. DIRECT CONTACT
Person to person transmission through contaminated fingers while carelessly handling excreta
and vomit of patients and contaminated linen and fomites.
6. OTHER CONDITIONS OF TRANSMISSION
Cholera transmission is closely linked to inadequate environmental management
Urban slums – where basic infrastructure is not available
Areas where consequences of disaster
Distruption of water and sanitation system
Displacement of population to inadequate and overcrowded camps
Poor drainage and contaminated food and water
Open air defection
7. EPIDEMIOLOGY
Cholera is both an epidemic and endemic disease.
The epidemicity and endemicity of the disease depends on characteristics of the agent and the
prevailing environment.
EPIDEMICS
Cholera are characteristically abrupt and often create an acute public health problem.
They have a high potential to spread fast and causes death.
Thus cholera epidemic in a community is self- limiting.
“ force of infection” – two components – infection through water and the contacts.
8. ENDEMICS
In areas where cholera is endemic, it does not show a stable endemicity like typhoid fever.
It undergoes seasonal fluctuations as well as epidemic outbreaks.
The seasonal variation differs between countries and even between regions of the same country.
Eg: the disease used to be most common in the summer in Kolkata and in early winter in
Bangladesh ; in both places frequent in autumn.
In some parts of India the peak incidence is in Augest.
9. EPIDEMIOLOGICAL DETERMINANTS
AGENT FACTORS
HOST FACTORS
ENVIRONMENTAL FACTORS
AGENT FACTORS
AGENT : agent which involves in the cause for cholera
1. The organism that causes cholera is labelled as V. cholera O group 1 or Vibrio choleraeO1
and O139.
2. Vibrio cholera are killed within 30mins by heating at 56 deg C or by boiling.
3. Infective material
4. Infective dose
10. HOST FACTORS
AGE AND SEX:
it affects all ages and both sexes.
in endemic areas , attack rate is higher in children
GASTRIC ACIDITY
An effective barrier. The vibrio is destroyed in an acidity of pH 5 or lower.
Conditions that reduce gastric acidity may influence individual susceptibility
POPULATION MOBILITY
Movement of population – like, pilgrimages, marriages , festivels.
In this cases carriers can easily transfer infection to other countries.
11. IMMUNITY
An attack of cholera is followed by immunity to reinfection, but the duration and degree if immunity are
not known.
Vibriocidal antibodies in serum have been associated with protection against colonization and disease
The presence of antitoxin , antibodies has not been associated with protection.
Vaccination gives only temporary, partial immunity for 3-6 months.
ENVIRONMENTAL FACTORS
Readily possible in a community with poor environmental
sanitation include contaminated water and food.
It comprise of favouring water and soil pollution, low standards of
personal hygiene, lack of education and poor quality of life.
12. PATHOPHYSIOLOGY
V.Cholerae accumulates in stomach
Produce toxins
Toxins will bind to G- protein coupled receptor
Inactivation of GTP ase
G- protein stuck in “on” position
Increase c AMP
Activation of ion channels
NaCl influx into intestinal lumen to drag water into lumen
Lead to watery diarrhoea
13.
14. DIAGNOSIS
Stool culture
Confirm presence of cholera toxin
Cholera rapid test dipsticks
STOOL CULTURE
Rectal swab method
Cather method
Blotting paper method
CONFRIM PRESENCE OF CHOLERA TOXIN
Culture of stool specimen on selective
thiosulfate – citrate- bile salts – sucrose (TCBS) agar plate
Yellow colonies are formed
CHOLERA RAPID TEST
The sensitivity and specificity of the test is not optimal
15. TREATMENT
REHYDRATION THERAPY
ANTIMICROBIAL THERAPY
REHYDRATION THERAPY
Oral – administered through oral route – powder or liquid dose
Intravenous – administered through I.V. route – parental dose
PHASES
Rehydration phase
1. restore normal hydration status , should take no more than 4 hours
2. lactated ringer solution is prefered over isotonic sodium chloride solution
3. 50-100ml/kg/hr
Maintanence phase
1. the goal of maintanence phase is maintain normal hydration status by replacing ongoing
losses.
2. the oral route is preferred , the use of ORS at a rate of 500-1000 ml/hr
3. fluids should never be restricted
16. ANTIMICROBIAL THERAPY
It is useful for
Prompt eradication of the vibrio
Diminish the duration of diarrhea
Decrease the fluids loss
Antibiotics should be administered to moderate or severe cases
AGE DRUG
Adults doxycycline , 300mg po single dose
Azithromycin 1g po single dose
Pregnant Erythromycin 500mg/ 6 hours for 3 days
Children >3yrs Erythromycin 12.5mg/kg/ 6 hours for 3 days
Children <3yrs Erythromycin 12.5mg/kg/ 6 hours for 3 days
17. CONTROL OF DISEASE
Verification of the diagnosis
Notification
Early case finding
Establishment of treatment centres
Rehydration therapy
Adjuncts to therapy
Epidemiological investigations
Sanitation measures
Chemoprophylaxis
Vaccinations
Health education
18. 1.VERIFICATION OF THE DIAGNOSIS
It is important to have conformation of the outbreak as soon as possible
It is very imoortant for the diagnosis of cholera in the early stages.
Once the presence of the cholera has been confirmed , it is necessary to culture stools of all cases or contacts
There should be a well organized system of laboratory services in the community
2.NOTIFICATION
Cholera is notifiable to the WHO within 24 hours of its occurance by the national government
The number of cases and deaths are also to be reported daily and weekly till the area is declared free of
cholera
3.EARLY CASE FINDINGS
Early detection of cases also permits the detection of infected house hold contacts and spread of the diseases
Early finding of the cases helps in control of the spread of the cholera
It take part in the making awareness and safety measures to reduce the spread of the cholera
19. 4.ESTABLISHMENT OF TREATMENT CENTRES
It is necessary to establish easily treatment facilities in the community
The mildly dehydrated patients should be treated at home with oral rehydration fluid
Severly dehydrated patients , requiring intravenous fluid should be admitted to the nearby hospital or
treatment centres
If less hospital facilities which are not sufficient , then the nearby school or govt. buildings can be take
over and converted into temporary treatment centres.
In the risk situation there should be a sufficient hospital or treatment centres with standard medical
facilities
5.REHYDRATION THERAPY
In cholera, the rehydration may be oral or intravenous
During vomiting and diarrhoea conditions there is a loss of electrolytes and body fluids from the body
Rehydration therapy involves in the retention of the electrolytes and body fluid in the body during the
diseased conditions
ORS ( Oral Rehydration Salt ) is the powder or in liquid dose which is majorly used in the rehydration
therapy.
20. REDUCED ORS gm/lit
NaCl 2.6
Glucose, anhydrous 13.5
Potassium chloride 1.5
Trisodium citrate,
dehydrate
2.9
Total weight 20.5
REDUCED ORS Mol/lit
Sodium 75
Chloride 65
Glucose, anhydrous 75
Potassium 20
Citrate 10
Total weight 245
Age <4
months
4-11
months
1-2 yrs 2-4 yrs 5-14 yrs 15yrs<
Weight(kg) <5 5-7.9 8-10.9 11-15.9 16-29.9 30<
ORS SOLUTION
(ml)
200-400 400-600 600-800 800-1200 1200-2200 2200-4000
Guidelines for oral rehydration therapy during first four hours
COMPOSITION OF ORS
21. 6.ADJUNCTS TO THERAPY
Antibiotics should be given as soon as vomiting has stopped
After 3 to 4 hours of oral rehydration
The commonly used antibiotics are
Flouroquinolones
Tetracyclines
Ampicilline
Azithromycin
No other medication should be given to cholera patients like antidiarrhoeals, antiemetics,
antispasmodics, steroids.
If diarrhoea perisists after 48hours of treatment , the antibiotic resistance is suspected
7.EPIDEMIOLOGY INVESTIGATION
Epidemiology studies must be undertaken to define the extent of the outbreak and identify the modes
of transmission so that specific control measures can be applied
22. 8. SANITATION MEASURES
a. WATER CONTROL
Water is the most important vehicle of transmission of cholera
All steps must be taken properly to provide safe water for drinking, cooking and washing
In rural areas water can be made safe by boiling or by chlorination
The drinking water should be stored in covered containers
b. FOOD SANITATION
Food is also a factor which involves in the infection
The food should be cooked full and stored in the closed containers
Cooking utensils should be cleaned and dried after use
The housefly play important role in transmission of disease so the food should be covered and
sanitation should be followed
c. DISINFECTION
The most effective disinfectant for general use is a coal disinfectant with Eideal-Walker (RW)
coefficient of 10 or more such as cresol
Bleaching powder used should be of good quality
Patients stools and vomiting cloths and other personal items should be washed with the
disinfectants and should be handle safely
23. 9.CHEMOPROPHYLAXIS
Chemopropylaxis refers to the administration of medication to prevent disease or infection.
In the case of cholera , healthy individuals are given antibiotics with the aim of protecting them
against the disease, limiting the spread of the disease and curtailing an epidemic.
Tetracycline is the drug of choice for chemopropylaxis.
It has to be given twice daily for 3 days at dose of 500mg for adults, 125mg for children (4-
13yrs), 50mg for children (0-3yrs).
A single oral dose of doxycycline – 300mg for adults and 6mg/kg for children under 15yrs.
10. VACCINATIONS
ORAL VACCINE
a. Dukoral (WC-rBS)
b. Sanchal and mORCVAX
11. HEALTH EDUCATION
Health education provides the knowledge about the disease and preventions
a. Food hygiene practices.
b. Hand washing after defecation and before eating.
c. The benefit of cooked , hot foods, and safe water.
24. PREVENTION
Drink and use hot or safe water
Wash hands often with soap and safe water
Cook food well, keep it in a covered , eat it hot, and peel fruits and vegetables
Clean up safely – in the kitchen and in places where the family bathes and washes cloths
Use flush toilets or approved septic system ; double bag soiled materials when discarding in trash
Possible , use rubber gloves when cleaning any room or surface that may contact with patients with
the patients fecal matter
Use any household disinfectant or a 1:10 dilution of bleach solution to clean any area that may
have contact with fecal matter including the patients
Personal hygiene should be followed in perfect guidelines.